- Diahn-Warng Perng
Taipei Veterans General Hospital, Taiwan
[Grand Ballroom 103 (1F)] 12:10-12:40 [Symposium35] COPD
Early Intervention of COPD with Mild Airflow Limitation
- Youlim Kim
Konkuk University Hospital, School of Medicine, Republic of Korea
[Grand Ballroom 103 (1F)] 11:40-12:10 [Symposium35] COPD
Defining of Early COPD in Korea
- Don Sin
University of British Columbia, St. Paul Hospital, Canada
[Grand Ballroom 103 (1F)] 11:10-11:40 [Symposium35] COPD
Importance of Early COPD in Young Adults for Development of Clinical COPD
- Anne E Vertigan
The University of Newcastle, Australia
[Grand Ballroom 102(1F)] 12:10-12:40 [Symposium34] Clinical Respiratory Medicine
The State of the Art for Refractory Cough: Multidisciplinary Approach
- Mona Bafadhel
King’s College London, United Kingdom
[Grand Ballroom 102(1F)] 11:40-12:10 [Symposium34] Clinical Respiratory Medicine
Theory and Practice of Chronic Cough: Special Cough Clinic
- Hyeon-Kyoung Koo
Inje University College of Medicine, Republic of Korea
[Grand Ballroom 102(1F)] 11:10-11:40 [Symposium34] Clinical Respiratory Medicine
Heterogenous Aspect of Chronic Cough: Differing Profile
- Parameswaran Nair
McMaster University, Canada
[Grand Ballroom 101(1F)] 12:10-12:40 [Symposium33] Asthma
Eosinophil-Mucus Complex Interplay in Severe Asthma
- Jung-Kyu Lee
Seoul National University, Republic of Korea
[Grand Ballroom 101(1F)] 11:40-12:10 [Symposium33] Asthma
Microbiome in Severe Asthma
- Nicola A Hanania
Baylor College of Medicine, USA
[Grand Ballroom 101(1F)] 11:10-11:40 [Symposium33] Asthma
Biomarker for Severe Asthma
- David A Schwartz
University of Colorado School of Medicine,
[Grand Ballroom 103 (1F)] 09:20-10:50 [Symposium32] Interstitial Lung Disease
The Role of Genetics in Idiopathic Pulmonary Fibrosis
- So Young Park
Hallym University College of Medicine, Republic of Korea
[Grand Ballroom 102(1F)] 10:20-10:50 [Symposium31] Lung Cancer
Symptom Relief Management in End-of Life Care
- Hye Ryoun Kim
Korea Institute of Radiological and Medical Sciences, Republic of Korea
[Grand Ballroom 102(1F)] 09:50-10:20 [Symposium31] Lung Cancer
Benefits and Barriers of Early Integrated Palliative Care in Lung Cancer Patients
- David Hui
University of Texas,
[Grand Ballroom 102(1F)] 09:20-09:50 [Symposium31] Lung Cancer
Evolution of Palliative Care and Models of Care Delivery
- Young-Jae Cho
Seoul National University Bundang Hospital, Seongnam, Republic of Korea
[Grand Ballroom 101(1F)] 10:20-10:50 [Symposium30] Critical Care Medicine
Reorganizing ICU after COVID-19 pandemic
- Jason Phua
Associate Professor, Division of Respiratory and Critical Care Medicine, National University Hospital,
[Grand Ballroom 101(1F)] 09:50-10:20 [Symposium30] Critical Care Medicine
Management of Acute Respiratory Failure in COVID-19
- Carolyn S Calfee
University of California, San Francisco, USA
[Grand Ballroom 101(1F)] 09:20-09:50 [Symposium30] Critical Care Medicine
Therapeutics of Critical COVID-19 Patients
- Ji-yong Moon
Hanyang University College of Medicine, Republic of Korea
[Grand Ballroom 102(1F)] 16:50-17:20 [Symposium29] Clinical Allergy & Immunology
Treatment of Biologics in Comorbidities of Asthma
- Koichiro Asano
Tokai University School of Medicine, Japan
[Grand Ballroom 102(1F)] 16:20-16:50 [Symposium29] Clinical Allergy & Immunology
Diagnosis and Treatment of ABPA
- Asger Sverrild
University Hospital Bispebjerg, Denmark
[Grand Ballroom 102(1F)] 15:50-16:20 [Symposium29] Clinical Allergy & Immunology
The Effect of Tezepelumab in Asthma
- Jun-Pyo Myong
The Catholic University of Korea College of Medicine, Republic of Korea
[Grand Ballroom 101(1F)] 16:50-17:20 [Symposium28] Environmental & Occupational Health and Epidemiology
Hospital Based Nation-Wide Survillance of Asbestos Related Diseases in Korea
- Akira Ogami
University of Occupational and Environmental Health,
[Grand Ballroom 101(1F)] 16:20-16:50 [Symposium28] Environmental & Occupational Health and Epidemiology
A Surveillance of Nanoparticle Exposured Workers and Their Respiratory Function, Japan Experience
- Martie Van Tongeren
The University of Manchester, United Kingdom
[Grand Ballroom 101(1F)] 15:50-16:20 [Symposium28] Environmental & Occupational Health and Epidemiology
UK Occupational and Environmental Surveillance Program
- Gong Yong Jin
Jeonbuk National University, Republic of Korea
[Auditorium (3F)] 16:50-17:20 [Symposium27] Interstitial Lung Disease
ILA in Asian Population
- Grace H Kim
UCLA,
[Auditorium (3F)] 16:20-16:50 [Symposium27] Interstitial Lung Disease
Evaluation of ILA by Automatic Quantification System
- Takeshi Johkoh
Kansan Rosai Hospital,
[Auditorium (3F)] 15:50-16:20 [Symposium27] Interstitial Lung Disease
ILA: Natural Course and Clinical Implication
- Carolyn S Calfee
University of California, San Francisco, USA
[Grand Ballroom 102(1F)] 14:00-14:40 [Symposium26] Critical Care Medicine
Meet the Professor: ARDS, Beyond & Next
- Jin-won Huh
University of Ulsan College of Medicine, Republic of Korea
[Grand Ballroom 101(1F)] 15:00-15:30 [Symposium25] Respiratory Infections (Non-Tuberculous)
Advances in the Management of Fungal Pneumonia in Critically Ill Patients
- Chieh-Liang Wu
Taichung Veterans General Hospital, Taiwan
[Grand Ballroom 101(1F)] 14:30-15:00 [Symposium25] Respiratory Infections (Non-Tuberculous)
Recent Advances in the Aspiration Pneumonia
- Girish B Nair
Oakland University William Beaumont School of Medicine, USA
[Grand Ballroom 101(1F)] 14:00-14:30 [Symposium25] Respiratory Infections (Non-Tuberculous)
Management of CAP in the Era of COVID-19
- Konstantinos Kostikas
University of Ioannina, Greece
[Auditorium (3F)] 14:25-14:45 [Symposium24] COPD
Con: Application of Bioinformatic Artificial Intelligence to Current Clinical Practice in the Management of COPD
